Geneviève Almouzni

I am a Director of Research from The National Centre for Scientific Research (CNRS) at the Curie Institute, France where I lead the Chromatin Dynamics team. I am a laureate of the 2024 L’Oréal-UNESCO For Women in Science International Awards.

I’m particularly passionate about understanding how our genome is organised and how this is important during development — normal, and in the context of disease, such as cancer.

EXPs by Geneviève Almouzni

Publications

Jeffery, D., Gatto, A., Podsypanina, K., et al. (2021). CENP-A overexpression promotes distinct fates in human cells, depending on p53 status. Communications Biology, 4, 417.
Torné, J., Ray-Gallet, D., Boyarchuk, E., et al. (2020). Two HIRA-dependent pathways mediate H3.3 de novo deposition and recycling during transcription. Nature Structural & Molecular Biology, 27, 1057–1068.
Morel, D., Jeffery, D., Aspeslagh, S., et al. (2020). Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise. Nature Reviews Clinical Oncology, 17, 91–107.
Sitbon, D., Boyarchuk, E., Dingli, F., et al. (2020). Histone variant H3.3 residue S31 is essential for Xenopus gastrulation regardless of the deposition pathway. Nature Communications, 11, 1256.
Simeonova, I., & Almouzni, G. (2019). Dynamic Histone H3 Incorporation Fuels Metastatic Progression. Trends in Molecular Medicine, 25(11), 933–935.
Müller, S., & Almouzni, G. (2017). Chromatin dynamics during the cell cycle at centromeres. Nature Reviews Genetics, 18, 192–208.

All publications

Website

Institut Curie

Shop

Histone Variants

Ma douce Mé: Marie Curie et sa fille Irène